Bank of Nova Scotia’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $932K | Buy |
33,782
+21,280
| +170% | +$587K | ﹤0.01% | 764 |
|
|
2025
Q1 | $354K | Sell |
12,502
-28,403
| -69% | -$805K | ﹤0.01% | 831 |
|
|
2024
Q4 | $1.7M | Buy |
40,905
+1,430
| +4% | +$59.5K | ﹤0.01% | 705 |
|
|
2024
Q3 | $2.64M | Buy |
39,475
+9,834
| +33% | +$657K | 0.01% | 597 |
|
|
2024
Q2 | $3.52M | Sell |
29,641
-2,113
| -7% | -$251K | 0.01% | 528 |
|
|
2024
Q1 | $3.38M | Sell |
31,754
-14,046
| -31% | -$1.5M | 0.01% | 566 |
|
|
2023
Q4 | $4.55M | Buy |
45,800
+18,574
| +68% | +$1.85M | 0.01% | 518 |
|
|
2023
Q3 | $2.81M | Buy |
27,226
+6,000
| +28% | +$620K | 0.01% | 514 |
|
|
2023
Q2 | $2.58M | Buy |
21,226
+8,644
| +69% | +$1.05M | 0.01% | 478 |
|
|
2023
Q1 | $1.93M | Sell |
12,582
-72,170
| -85% | -$11.1M | 0.01% | 552 |
|
|
2022
Q4 | $15.2M | Sell |
84,752
-72,046
| -46% | -$12.9M | 0.04% | 278 |
|
|
2022
Q3 | $18.5M | Sell |
156,798
-13,465
| -8% | -$1.59M | 0.06% | 232 |
|
|
2022
Q2 | $24.3M | Sell |
170,263
-23,968
| -12% | -$3.42M | 0.06% | 245 |
|
|
2022
Q1 | $33.5M | Sell |
194,231
-48,699
| -20% | -$8.39M | 0.06% | 270 |
|
|
2021
Q4 | $61.8M | Buy |
242,930
+135,395
| +126% | +$34.4M | 0.09% | 197 |
|
|
2021
Q3 | $41.4M | Sell |
107,535
-42,573
| -28% | -$16.4M | 0.07% | 218 |
|
|
2021
Q2 | $35.3M | Buy |
150,108
+146,747
| +4,366% | +$34.5M | 0.07% | 224 |
|
|
2021
Q1 | $440K | Sell |
3,361
-2,430
| -42% | -$318K | ﹤0.01% | 946 |
|
|
2020
Q4 | $605K | Sell |
5,791
-2,355
| -29% | -$246K | ﹤0.01% | 822 |
|
|
2020
Q3 | $576K | Buy |
8,146
+1
| +0% | +$71 | ﹤0.01% | 802 |
|
|
2020
Q2 | $523K | Buy |
+8,145
| New | +$523K | ﹤0.01% | 736 |
|